Laxmi Dental Q4FY26: Revenue at ₹74 Cr, Up 21.9% YoY; PAT ₹10.09 Cr
Laxmi Dental reported highest-ever quarterly revenue of ₹74 Cr for Q4FY26, a 21.9% YoY increase. Full year revenue stood at ₹278 Cr. EBITDA and PAT margins were 18.3% and 13.6% for Q4FY26 respectively. Dental Laboratory business grew 27% YoY, and Aligner Solutions business reported ₹18 Cr revenue.
The announcement provides a detailed financial update with strong growth figures, which is material for investors. However, it does not include any major new strategic announcements or significant future guidance that would warrant a 'HIGH' impact.
The company reported strong year-on-year growth in revenue and healthy margins for the quarter, along with a positive outlook and growth in key business segments.
Laxmi Dental Limited announced its financial results for the fourth quarter and full year ended March 31, 2026. The company reported its highest-ever quarterly revenue at ₹74 crore for Q4FY26, marking a 21.9% year-on-year growth. The EBITDA and PAT margins for the quarter stood at healthy levels of 18.3% and 13.6% respectively, despite facing higher US tariffs in the first half of the quarter.
For the full fiscal year FY26, the company's revenue reached ₹278 crore, with an EBITDA margin of 15.6% and a PAT margin of 10.4%. This performance was achieved amidst multiple operational challenges related to the macro-economic environment and geopolitical situations.
The Dental Laboratory business demonstrated robust growth, reporting a 27% YoY increase driven by strong domestic recovery and highest-ever international revenue. The Aligner Solutions business also performed well, generating ₹18 crore in revenue during the quarter. Bizdent, the clear aligner business, saw an 11% YoY growth, while Vedia, the aligner raw material business, remained stable sequentially with ₹7 crore in revenue, though impacted by higher freight costs in March due to geopolitical uncertainties.
The company highlighted its continuous efforts towards digitalization, with digital penetration in the Indian Dental business reaching approximately 80%. The management attributed the performance to ongoing business expansion, strategic innovation, the inherent strength of its core dental operations, and sustained investments in branding and product development.
What to do with a filing like this
Laxmi Dental Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Laxmi Dental Limited. Read the original for the full detail.